Quantitative

• Published in: Oncology letters Vol. 16; no. 4; p. 4129
• Main Authors: Ma, Wenchao, Xu, Wengui, Li, Xiaofeng, Song, Xiuyu, Huang, Hui, Zhu, Yanjia, Wang, Minshu, Dai, Dong
• Format: Journal Article
• Language: English
• Published: Spandidos Publications 01.10.2018
• Subjects: Care and treatment; CAT scans; Diagnosis; Non-small cell lung cancer; Positron emission tomography
• ISSN: 1792-1074

The aim of the present study was to investigate the prognostic value of quantitative [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) parameters for patients with non-small cell lung cancer (NSCLC). The present study conducted a retrospective review of the medical records of 203 patients with NSCLC, of which 193 patients underwent baseline (18)F-FDG PET/CT prior to initial therapy. Multivariate analyses using Cox's proportional hazards regression were performed for the assessment of the association between initial PET/CT measurements and overall survival (OS). The multivariate models were adjusted for sex, age, smoking status, disease stage, standardized uptake value (SUV), standardized uptake value corrected for lean body mass (SUL), metabolic tumor volume (MTV), total lesion glycolysis (TLG) and standard deviation of SUV (SD). Kaplan-Meier (K-M) estimator curves were constructed following the formation of three approximately equal-sized groups using tertiles for each PET/CT measurement (n=65, 64 and 64). OS curves were plotted using K-M estimator curves. Results demonstrated significant associations (between) (OS) (and) (MTV)PET volume computerized assisted reporting (PETVCAR) MTV2.5, MTV25%, MTV42% and TL[G.sub.PETVCAR]; however, no significant associations were identified between OS and MTV50%, MTV75%, TLG2.5, all SUV and SUL. Subgroup analyses according to pathology demonstrated that there were statistically significant associations between OS and stage (P<0.001), MTV50% (P=0.002) and MTV42% (P=0.004) in the adenocarcinoma group, and SU[L.sub.mean] (P=0.010), MTV25% (P=0.005) and MTV42% (P=0.001) in the squamous cell carcinoma group; however, no significant differences were identified between any other group. Furthermore, there was a significant association between OS and MTV42% (P=0.02) and MTV50% (P=0.04) in the early-stage group; however, no significant differences were identified in the advanced-stage group. K-M estimator curve analyses demonstrated that the pathology (P=0.01), stage (P<0.001) and all PET metabolic parameters with the exception of SD were significantly associated with OS (P<0.05). No significant associations were demonstrated between SD and OS. In conclusion, (18)F-FDG PET/CT MT[V.sub.PETVCAR], MTV2.5, MTV25%, MTV42% and TL[G.sub.PETVCAR] exhibit prognostic values with regard to OS. Overall, selection of appropriate metabolic parameters may predict NSCLC prognosis.